1. Home
  2. RELL vs LCTX Comparison

RELL vs LCTX Comparison

Compare RELL & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RELL
  • LCTX
  • Stock Information
  • Founded
  • RELL 1947
  • LCTX 1990
  • Country
  • RELL United States
  • LCTX United States
  • Employees
  • RELL N/A
  • LCTX N/A
  • Industry
  • RELL Electronic Components
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RELL Technology
  • LCTX Health Care
  • Exchange
  • RELL Nasdaq
  • LCTX Nasdaq
  • Market Cap
  • RELL 138.8M
  • LCTX 107.3M
  • IPO Year
  • RELL N/A
  • LCTX N/A
  • Fundamental
  • Price
  • RELL $9.93
  • LCTX $1.07
  • Analyst Decision
  • RELL
  • LCTX Strong Buy
  • Analyst Count
  • RELL 0
  • LCTX 5
  • Target Price
  • RELL N/A
  • LCTX $4.20
  • AVG Volume (30 Days)
  • RELL 41.3K
  • LCTX 4.3M
  • Earning Date
  • RELL 07-23-2025
  • LCTX 08-07-2025
  • Dividend Yield
  • RELL 2.45%
  • LCTX N/A
  • EPS Growth
  • RELL N/A
  • LCTX N/A
  • EPS
  • RELL N/A
  • LCTX N/A
  • Revenue
  • RELL $204,394,000.00
  • LCTX $9,557,000.00
  • Revenue This Year
  • RELL $9.48
  • LCTX N/A
  • Revenue Next Year
  • RELL $4.10
  • LCTX $232.66
  • P/E Ratio
  • RELL N/A
  • LCTX N/A
  • Revenue Growth
  • RELL N/A
  • LCTX 19.42
  • 52 Week Low
  • RELL $7.57
  • LCTX $0.37
  • 52 Week High
  • RELL $15.51
  • LCTX $1.15
  • Technical
  • Relative Strength Index (RSI)
  • RELL 54.78
  • LCTX 65.71
  • Support Level
  • RELL $9.71
  • LCTX $0.97
  • Resistance Level
  • RELL $10.06
  • LCTX $1.09
  • Average True Range (ATR)
  • RELL 0.32
  • LCTX 0.11
  • MACD
  • RELL 0.02
  • LCTX -0.00
  • Stochastic Oscillator
  • RELL 62.97
  • LCTX 73.30

About RELL Richardson Electronics Ltd.

Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. Its products have applications in alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. The company segments include PMT (Power and Microwave Technologies Group), Canvys, (Green Energy Solutions) GES, and Healthcare reportable segments. The company derives the majority of its revenues from the PMT segment.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: